Suppr超能文献

多嘧啶核苷酸结合蛋白对 CaV1.2 钙通道转录本中互斥外显子 8a 和 8 的调控。

Regulation of the mutually exclusive exons 8a and 8 in the CaV1.2 calcium channel transcript by polypyrimidine tract-binding protein.

机构信息

Howard Hughes Medical Institute, UCLA, Los Angeles, California 90095, USA.

出版信息

J Biol Chem. 2011 Mar 25;286(12):10007-16. doi: 10.1074/jbc.M110.208116. Epub 2011 Jan 31.

Abstract

CaV1.2 calcium channels play roles in diverse cellular processes such as gene regulation, muscle contraction, and membrane excitation and are diversified in their activity through extensive alternative splicing of the CaV1.2 mRNA. The mutually exclusive exons 8a and 8 encode alternate forms of transmembrane segment 6 (IS6) in channel domain 1. The human genetic disorder Timothy syndrome is caused by mutations in either of these two CaV1.2 exons, resulting in disrupted Ca(2+) homeostasis and severe pleiotropic disease phenotypes. The tissue-specific pattern of exon 8/8a splicing leads to differences in symptoms between patients with exon 8 or 8a mutations. Elucidating the mechanisms controlling the exon 8/8a splicing choice will be important in understanding the spectrum of defects associated with the disease. We found that the polypyrimidine tract-binding protein (PTB) mediates a switch from exon 8 to 8a splicing. PTB and its neuronal homolog, nPTB, are widely studied splicing regulators controlling large sets of alternative exons. During neuronal development, PTB expression is down-regulated with a concurrent increase in nPTB expression. Exon 8a is largely repressed in embryonic mouse brain but is progressively induced during neuronal differentiation as PTB is depleted. This splicing repression is mediated by the direct binding of PTB to sequence elements upstream of exon 8a. The nPTB protein is a weaker repressor of exon 8a, resulting in a shift in exon choice when nPTB replaces PTB in cells. These results provide mechanistic understanding of how these two exons, important for human disease, are controlled.

摘要

钙通道 1.2(CaV1.2)钙通道在多种细胞过程中发挥作用,例如基因调控、肌肉收缩和膜兴奋,并且通过 CaV1.2 mRNA 的广泛选择性剪接而在其活性方面多样化。相互排斥的外显子 8a 和 8 编码通道结构域 1 中的跨膜片段 6(IS6)的替代形式。人类遗传疾病 Timothy 综合征是由这两个 CaV1.2 外显子中的任一个突变引起的,导致 Ca(2+)稳态紊乱和严重的多效性疾病表型。外显子 8/8a 剪接的组织特异性模式导致 8 外显子或 8a 突变患者之间症状的差异。阐明控制外显子 8/8a 剪接选择的机制对于理解与该疾病相关的缺陷谱将是重要的。我们发现多嘧啶tract 结合蛋白(PTB)介导从外显子 8 到 8a 剪接的转换。PTB 及其神经元同源物 nPTB 是广泛研究的剪接调节剂,可控制大量的替代外显子。在神经元发育过程中,PTB 的表达下调,同时 nPTB 的表达增加。外显子 8a 在胚胎小鼠脑中基本受到抑制,但随着 PTB 的耗尽,在神经元分化过程中逐渐被诱导。这种剪接抑制是通过 PTB 直接结合外显子 8a 上游的序列元件介导的。nPTB 蛋白是外显子 8a 的较弱抑制剂,导致当 nPTB 在细胞中取代 PTB 时,外显子选择发生转变。这些结果提供了对这两个外显子(对人类疾病很重要)如何受到控制的机制理解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验